CAS No.: 668270-12-0
Molecular formula: C25H28N8O2
Molecular weight: 472.54
Related categories: Pharmaceutical intermediates, pharmaceutical raw materials, fine chemicals.
...
Nature
Melting point | 202 ºC |
density | 1.39 |
Use
Lilacitin, developed by Boehringer Ingelheim, was approved by the FDA on May 2, 2011 for the control of blood glucose levels in people with type 2 diabetes by combining diet and exercise. Lilacitide improves glycemic control in patients by inhibiting dipeptidyl peptidase-4 (DPP-4).
After 26 years business done, we have excellent knowledge in the Chinese market. We provide the best price/quality ratio to satisfy requirements of global market.
dlsky@dlskychem.com
+86-411-86487833
